Trial Profile
Pretreatment of patients expecting bariatric surgery with GLP-1 analog Liraglutide.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 23 Apr 2021 Status changed from recruiting to discontinued.
- 24 Feb 2012 New trial record